WASHINGTON — Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules that Pfizer says are blocking it from helping seniors pay for an expensive heart condition drug.
The lawsuit, which was filed in a federal court in New York Friday, concerns two planned copay assistance programs for Pfizer’s drug tafamidis, which treats a rare fatal heart disease, transthyretin amyloid cardiomyopathy. The company is hoping to overturn two long-standing federal policies: one that prevents drug makers from directly paying part of seniors’ drug bills, and another that keeps drug makers from coordinating directly with outside charities that offer similar programs.
About the Author Reprints
